24/7 Patient Assistance: 760-405-8205

Guru Sonpavde, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Guru Sonpavde graduated the medical school from Christian Medical College Vellore and completed his residency program at Nassau University Medical Center. A fellowship at Indiana University School of Medicine followed soon after that. Dr. Sonpavde is specialized in Medical Oncology and board certified in Hematology, Internal Medicine and Medical Oncology. He has been in practice for more than 20 years and is affiliated with University of Alabama Hospital. During his career, he has also contributed to several publications of medical interest.



  • Education & Training

    dept_icon

    Christian Medical College Vellore

    Medical School

    dept_icon

    Nassau University Medical Center

    Residency

    dept_icon

    Indiana University School of Medicine

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    UAB Hospital

    Languages: English/Spanish

    (205) 934-3411

    1802 6th Ave S

    Birmingham, Alabama 35233

    Read More
  • Publications & Memberships

    Dr. Guru Sonpavde has contributed to 3 publications.

    Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.

    Ghatalia P, Yang ES, Lasseigne BN, Ramaker RC, Cooper SJ, Chen D, Sudarshan S, Wei S, Guru AS, Zhao A, Cooper T, Della Manna DL, Naik G, Myers RM, Sonpavde G; PLoS One. 2016.

    See more >>

    Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma.

    Leiter A, Doucette J, Krege S, Lin CC, Hahn N, Ecke T, Sonpavde G, Bamias A, Oh WK, Galsky MD; Bladder Cancer. 2016.

    See more >>

    Immunotherapy of advanced renal cell carcinoma: Current and future therapies.

    Gill D, Hahn AW, Sonpavde G, Agarwal N; Hum Vaccin Immunother. 2016 Aug 5.

    See more >>